FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma
About this item
Full title
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma
Author / Creator
Publisher
New York: Springer US
Journal title
Annals of surgical oncology, 2015-10, Vol.22 (11), p.3512-3521
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Background
Reports show that FOLFIRINOX therapy for pancreatic ductal adenocarcinoma (PDAC) results in objective response rates two to threefold higher than those of other regimens. This study aimed to assess response and resection rates for locally unresectable (stage 3) patients initially treated with induction FOLFIRINOX.
Methods
The in...
Alternative Titles
Full title
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1828167680
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1828167680
Other Identifiers
ISSN
1068-9265
E-ISSN
1534-4681
DOI
10.1245/s10434-015-4647-4
